Questions remain regarding the minimal safe hematocrit (Hct) level during cardiopulmonary bypass (CPB) in cardiac surgery. There is conflicting data in the literature on the association between low Hct, renal failure, transfusion and clinical outcomes. This prospective randomized controlled trial is an attempt to address some of these questions and provide a base for further investigation.